Needham & Company LLC Begins Coverage on Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Xavier Trudeau
Juillet 20, 2017

Brokerage houses, on average, are recommending investors to buy Walgreens Boots Alliance, Inc. However the price at the close of last session was -2.00% lower than its 50-day moving average and -4.22% under its 200-day moving average.

In the last reported quarter, Walgreens Boots Alliance reported its Actual EPS (earnings per share) of $1.33/share where most of the analysts working on this stock were estimating the EPS to be $1.3/share. Orrstown Financial Services Inc. increased its position in Walgreens Boots Alliance by 14.1% in the second quarter. The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.03. The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. The company has a market capitalization of $84.44 billion, a PE ratio of 19.93 and a beta of 1.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The company presently has a consensus rating of "Buy" and an average target price of $90.69. Analyst's mean target price for WBA is $92.95 while analysts mean recommendation is 2.00. To fully grasp the existing nature of the stock, a trader will need to know the company's stock price to its revenues. Modera Wealth Management LLC increased its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter.

Hedge funds and other institutional investors have recently bought and sold shares of the stock.

Stock of Walgreens Boots Alliance, Inc.

The 52-week high for Walgreens Boots Alliance, Inc. stands at -10.33% while the 52-week low stands at 4.96%.

Walgreens Boots Alliance (NASDAQ:WBA) now has a trailing P/E of 19.87 while its forward P/E according to Thomson Reuters is 14.25. Finally, Pitcairn Co. boosted its position in Walgreens Boots Alliance by 3.3% in the fourth quarter. Equities analysts expect that Walgreens Boots Alliance will post $5.01 earnings per share for the current year. Linscomb & Williams Inc. now owns 45,139 shares of the pharmacy operator's stock valued at $3,736,000 after buying an additional 1,171 shares during the last quarter. The P/S ratio for Walgreens Boots Alliance, Inc.is 0.71. Citigroup Inc reiterated a "buy" rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Total Debt/Equity is 61.01 and the Book value per Share is 28.6. Following the completion of the sale, the director now owns 21,887 shares of the company's stock, valued at approximately $1,879,874.43. The company had revenue of $30.12 billion during the quarter, compared to analysts' expectations of $29.72 billion. Aristotle Capital Management LLC now owns 3,471,692 shares of the pharmacy operator's stock valued at $287,317,000 after buying an additional 74,281 shares in the last quarter. During the same period a year ago, the company earned $1.18 EPS.

On October 17 the stock rating was upgraded to "Buy" from "Hold" in a report issued by Jefferies. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator's stock valued at $40,115,000 after buying an additional 203,635 shares in the last quarter. Webster Bank N.A. now owns 1,509 shares of the pharmacy operator's stock worth $125,000 after buying an additional 235 shares during the last quarter. The average volume for the existing shares outstanding is 5031.22.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th will be issued a dividend of $0.40 per share. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases.

Price/Earnings to growth ratio for the company is 1.44 and the stock shows its Price/Sales (ttm) of 0.72 and Price/Book for the most recent quarter of 2.75.

According to Yahoo Finance, The Dividend Date for Walgreens Boots Alliance is Sep 12, 2017 and its Ex-Dividend Date is May 16, 2017. If you are viewing this report on another website, it was illegally stolen and reposted in violation of USA and global copyright and trademark legislation. Stock repurchase programs are typically a sign that the company's board of directors believes its stock is undervalued. This is a positive change from Walgreens Boots Alliance's previous quarterly dividend of $0.38. The legal version of this news story can be read at https://www.thestockobserver.com/2017/07/18/walgreens-boots-alliance-sees-unusually-large-options-volume-wba-updated-updated-updated.html. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL